MEDP Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
707.3M
+0.1%
706.6M
-0.3%
708.5M
+7.4%
659.9M
+9.4%
603.3M
Cost of Revenue
505.7M
-0.9%
510.3M
+1.4%
503.1M
+8.7%
463.0M
+9.4%
423.3M
Gross Profit
201.6M
+2.7%
196.3M
-4.4%
205.3M
+4.3%
196.9M
+9.4%
180.0M
Operating Expenses
54.8M
-0.0%
54.8M
+5.3%
52.0M
-5.6%
55.1M
+2.7%
53.7M
R&D
0
0
0
0
0
SG&A
48.1M
+0.4%
47.9M
+6.7%
44.9M
-6.6%
48.1M
+3.0%
46.7M
Operating Income
146.8M
+3.8%
141.5M
-7.7%
153.3M
+8.1%
141.8M
+12.2%
126.3M
EBITDA
153.5M
+3.5%
148.4M
-7.5%
160.4M
+7.8%
148.9M
+11.6%
133.3M
Net Income
121.4M
-2.0%
123.9M
-8.3%
135.1M
+21.6%
111.1M
+23.1%
90.3M
EPS (Basic)
$4.31
-0.9%
$4.35
-9.0%
$4.78
+21.0%
$3.95
+25.0%
$3.16
EPS (Diluted)
$4.25
-0.7%
$4.28
-8.4%
$4.67
+21.0%
$3.86
+24.5%
$3.10
Shares (Diluted)
28.6M
-1.4%
29.0M
+0.0%
29.0M
+0.5%
28.8M
-1.1%
29.1M
Medpace (MEDP) โ€” Financials